A23V 2400/245
Salivarius
A23V2400/245 (Salivarius) appears on 15 US grants and 17 published applications in this corpus.
Search patents in A23V- Granted patents
- 15
- Published applications
- 17
- Assignees
- 8
- Inventors
- 31
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 3 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 4 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
| 2025 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section4 Nov 2025US 12,458,655 B2Societe des Produits Nestle S. A.
- Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children15 Jul 2025US 12,357,647 B2Societe des Produits Nestle S. A.
- Probiotics and probiotic compositions for regulating body weight19 Nov 2024US 12,144,836 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Probiotics and probiotic compositions for regulating body weight2 May 2023US 11,638,727 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Fermented nutritional composition for cow's milk protein allergic subjects27 Dec 2022US 11,533,941 B2Societe des Produits Nestle S. A.
- Probiotics and probiotic compositions for regulating body weight6 Jul 2023US 2023/0210918 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Fermented nutritional composition for cow's milk protein allergic subjects16 Mar 2023US 2023/0079243 A1Societe des Produits Nestle S. A.
- Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children13 Jan 2022US 2022/0008444 A1Societe des Produits Nestle S. A.
- Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section29 Jul 2021US 2021/0228602 A1Societe des Produits Nestle S. A.
- Probiotics and probiotic compositions for regulating body weight17 Dec 2020US 2020/0390829 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
Most cited
By later US patents
- Lactic acid bacteria, antibacterial substance produced by the bacteria, fermented milk starter containing the bacteria, and process for producing fermented milk by using the starter25US 5,482,723 ASnow Brand Milk Products Co., Ltd. · 1996
- Lactic acid bacteria, antibacterial substance produced by the bacteria, fermented milk starter containing the bacteria, and process for producing fermented milk by using the starter18US 5,338,682 ASnow Brand Milk Products Co., Ltd. · 1994
- Antimicrobial composition10US 7,226,590 B2Blis Technologies Limited · 2007
- Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section3US 10,940,158 B2Societe des Produits Nestle S. A. · 2021
- Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children2US 11,020,413 B2Societe des Produits Nestle S. A. · 2021